Quantcast

ChromaDex to Present at the World Tea Expo

June 2, 2010

IRVINE, Calif., June 2 /PRNewswire-FirstCall/ — ChromaDex Corporation (OTC Bulletin Board: CDXC), a world leader in phytochemical reference standards and contract testing services, announced that Frank Jaksch, president and co-founder, will be presenting on emerging beverage ingredients at the World Tea Expo on Sunday, June 13 at 9:45 a.m. PT at the Las Vegas Convention Center in Las Vegas, NV.

The presentation, entitled “Executive and Technical Series: Fact or Fiction – The Science Behind Emerging Beverage Ingredients,” will discuss the science and analytical testing behind a number of emerging beverage ingredients, including white tea, pu’erh, stevia, kombucha and yerba mate.

“Energy drinks and functional beverage shots have exploded out of the gate in the last decade, promising consumers exotic ingredients with extraordinary health claims,” said Frank Jaksch of ChromaDex. “There is a growing need for quality assurance in today’s tea market and it is important to know the difference between which emerging ingredients will be here to stay and which will be a flash in the pan.”

In February, the Company launched a new verification program for tea products that will provide suppliers with the assurance they need to meet product standards and a ChromaDex Verification Mark that will give consumers greater confidence in the quality of tea products.

This program encompasses nearly all aspects of tea product verification, including the identity of the raw tea material, the verification that no unwanted contaminants are present, and confirms the amount of catechin, theaflavin, xanthine alkaloids and polyphenols contained in the tea product. Successfully completing one or all of the verification plan components allows the supplier to display the ChromaDex Verification Mark on their products and be included in a verified products list on the ChromaDex Web site.

The World Tea Expo is the annual business-to-business trade event for the $7 billion specialty tea industry where industry members determine trends, optimize product lines, increase knowledge and network with peers. For more information, visit www.worldteaexpo.com.

About ChromaDex

ChromaDex is a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property. ChromaDex is committed to sustainable “green chemistry” and provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the novel ingredients, analytical tools and services to meet product regulatory, quality, efficacy and safety standards. Among other things, the Company is currently focusing on clinical studies and the commercialization of its new product, pTeroPure(TM) pterostilbene (www.pteropure.com) as a result of its exclusive worldwide patent rights for pterostilbene. For more information, visit www.chromadex.com or follow ChromaDex on Twitter @ChromaDex.

Forward-Looking Statements

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to: the ability to market, produce and sell the referenced ingredients; risks relating to product and customer demand, market acceptance of our products; the effect of economic conditions both nationally and internationally; the ability to protect our intellectual property rights; the impact of any litigation or infringement actions brought against us; competition from other providers and products; risks in product development; our ability to raise capital to fund continuing operations; the ability to complete transactions; and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.


    Investor Inquiries
    Liviakis Financial Communications, Inc.
    John M. Liviakis, President
    415-389-4670
    John@Liviakis.com

    ChromaDex Contact
    Jenny Robles
    Administrative Assistant to the CEO
    10005 Muirlands Blvd, Suite G, Irvine, CA 92618
    949-419-0288
    jennyr@chromadex.com

    Media Contact
    Megan Lavine
    Canale Communications
    3033 5th Ave., Suite 400, San Diego, CA 92103
    619-849-5388
    megan@canalecomm.com

SOURCE ChromaDex Corporation


Source: newswire



comments powered by Disqus